石学敏院士醒脑开窍针刺法的临床应用与基础研究.ppt

结论：长期的实验室安全数据显示：两组间无统计学差异证明了丹芪在对中风急性期患者治疗的3个月中的安全性。 Conclusions： Longer-term laboratory safety data showed no differences between MLC601 and placebo, confirming the safety of MLC601 in acute stroke patients receiving a 3-month treatment. 题目：A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of the traditional chinese medicine Neuroaid (MLC 601) in enhancing recovery after stroke (TIERS). 丹芪偏瘫胶囊治疗中风后恢复期的二期临床研究：随机、对照、双盲试验 杂志：Cerebrovascular diseases 脑血管病杂志 瑞士 影响因子：2.871 作者：Keng He Kong, 新加坡，宏茂桥医院 Ang Mo Kio Hospital,Singapore 研究